Tirzepatide is a groundbreaking treatment agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, resulting in synergistic Tirzepatide 30mg effects on blood glycemic control. By enhancing insulin secretion and re